• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MEDTRONIC SURGICAL TISSUE VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MEDTRONIC SURGICAL TISSUE VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number MDT-TISSUE VALVE
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Atrial Fibrillation (1729); Stroke/CVA (1770); Endocarditis (1834); Hemorrhage/Bleeding (1888); Unspecified Infection (1930)
Event Date 04/25/2020
Event Type  Injury  
Manufacturer Narrative
Citation: tamirat et al.Contemporary outcomes of aortic and mitral valve surgery for rheumatic heart disease in (b)(6).J thorac cardiovasc surg.(b)(6) 2021;162(6):1714-1725.E2.Doi: 10.1016/j.Jtcvs.2020.02.139.Epub (b)(6) 2020.Earliest date of publish used for date of event.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding outcomes of aortic and mitral valve surgery for rheumatic heart disease in (b)(6).All data were collected from a (b)(6) center between 2009 and 2017.The study population included 240 patients (predominantly female, mean age 19 years).Multiple manufacturer¿s devices were implanted in the study population.Among all patients eight were implanted with a medtronic porcine bioprosthetic valve (n=2) or mechanical valve (n=6) in either the aortic or mitral valve position.No model names or other unique device identifier numbers were provided.Among all bioprosthetic and mechanical valve patients, adverse events included: stroke, major bleeding requiring intervention, endocarditis, svd, new onset atrial fibrillation (afib), and wound infection.Based on the available information medtronic product may have been associated with the adverse event(s).No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEDTRONIC SURGICAL TISSUE VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key14115946
MDR Text Key290694863
Report Number2025587-2022-00988
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeET
PMA/PMN Number
P970031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 04/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/14/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberMDT-TISSUE VALVE
Device Catalogue NumberMDT-TISSUE VALVE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/16/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention; Hospitalization;
Patient Age19 YR
Patient SexFemale
-
-